市場調查報告書
商品編碼
1377103
乾眼症產品的全球市場(2023年):2022年~2028年的分析2023 Dry Eye Products Market Report: Global Analysis for 2022 to 2028 |
本報告提供全球乾眼症產品市場相關調查,市場概要,以及今後5年的市場效能預測,重要的未來趨勢,及加入此市場的主要29企業企業簡介等資訊。
The "2023 Dry Eye Products Market Report" now covers more device and pharmaceutical treatment options, including generic, prescription, and over-the-counter. The report features new optometrist survey data, updated disease modeling, and expanded risk factor analysis. The report now forecasts service and handpiece revenue for procedures, when relevant. It profiles 29 market competitors and covers over 100 more companies that participate in this market.
Market Scope's "2023 Dry Eye Products Market Report" analyzes the current marketplace and forecasts market performance through 2028. The report examines dry eye syndrome's etiology, diagnosis, and treatment and provides in-depth coverage on the prevalence of dry eye, prescription therapeutics, over-the-counter lubricants, thermal expression, IPL, punctum plugs, and additional dry eye procedures and products. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-nine market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.
Our report is designed to provide depth and context to the reader's understanding of market dynamics in this ophthalmic segment. Our coverage includes:
Bill Freemanhas more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.
Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.
CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.
In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.